Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000791637 | SCV000930895 | uncertain significance | Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative | 2022-05-27 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 159 of the CYBA protein (p.Pro159Ser). This variant is present in population databases (rs558222148, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with CYBA-related conditions. ClinVar contains an entry for this variant (Variation ID: 638954). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001271482 | SCV001452671 | uncertain significance | Chronic granulomatous disease | 2020-01-24 | no assertion criteria provided | clinical testing |